Autism Stem-Cell Therapy to Be Tested in Children in Trials

Published August 21, 2012 in Bloomberg

Sutter Neuroscience Institute and CBR (Cord Blood Registry) are launching the first FDA-approved clinical trial to assess the use of a child’s own cord blood stem cells to treat select patients with autism.

Filed under: , ,